Successful 2-year therapy with systemic interferon-alpha for HTLV-I associated myelopathy.
Gazzola
P
P
Cocito
L
L
De Maria
A
A
Gabutti
G
G
Mancardi
G L
GL
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015493:Paraparesis, Tropical Spastic / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha